NewGenIvf (NIVF) EBIT Margin (2024 - 2025)
NewGenIvf (NIVF) posted quarterly EBIT Margin of 349.13% for Q4 2025, down 26362.0% year-over-year from N/an in Q4 2024, and down 78.18% quarter-over-quarter from 195.94% in Q3 2025.
NewGenIvf (NIVF) EBIT Margin (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported EBIT Margin for 2 consecutive years, with 349.13% the latest figure, recorded in Q4 2025.
- In Q4 2025, EBIT Margin fell 26362.0% year-over-year to 349.13%; the TTM figure through Dec 2025 stood at 153.28% (changed N/A YoY), while the FY2025 annual figure was 226.95%, down 20559.0% from the prior year.
- EBIT Margin declined to 349.13% in Q4 2025 per NIVF's latest filing, from 195.94% in the prior quarter.
- Across five years, EBIT Margin topped out at 14.69% in Q3 2024 and bottomed at 349.13% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -12.60% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 26.67% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 2.10% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 16.29% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 8.50% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 11.14% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 7.66% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 13.25% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 18.99% |
| 10 | NewGenIvf | 9,048.24 | -1.43 Mn | 524,025.00 | -349.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -349.13% |
| Sep 30, 2025 | -195.94% |
| Dec 31, 2024 | -85.51% |
| Sep 30, 2024 | 14.69% |